431917214	431917214	CD	B-NP	O
|	|	NNP	I-NP	O
TVGH	TVGH	NNP	I-NP	O
|	|	VBD	B-VP	O
51217568	51217568	CD	B-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
0176865	0176865	CD	B-NP	O
|	|	CC	I-NP	O
5/4/2005	5/4/2005	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
CHF	CHF	NN	I-NP	I-protein
exacerbation	exacerbation	NN	I-NP	O
,	,	,	O	O
cellulitis	cellulitis	NN	B-NP	O
|	|	NNP	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
5/4/2005	5/4/2005	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
6/8/2005	6/8/2005	CD	B-NP	O
******	******	SYM	I-NP	O
FINAL	FINAL	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	O	O
WHITLATCH	WHITLATCH	NNP	B-NP	O
,	,	,	O	O
JERROD	JERROD	NNP	B-NP	O
D	D	NNP	I-NP	O
270-16-79-6	270-16-79-6	NNP	I-NP	O
Ph	Ph	NNP	I-NP	O
Obeth	Obeth	NNP	I-NP	O
Pend	Pend	NNP	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
MED	MED	NNP	B-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
PATIENT	PATIENT	NNP	I-NP	O
ON	ON	NNP	I-NP	O
:	:	:	O	O
3/23/05	3/23/05	CD	B-NP	O
AT	AT	NN	I-NP	O
05	05	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
PM	PM	NNP	I-NP	O
CONTINGENT	CONTINGENT	NNP	I-NP	O
UPON	UPON	NNP	I-NP	O
Not	Not	NNP	I-NP	O
Applicable	Applicable	NNP	I-NP	O
WILL	WILL	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
BALCOS	BALCOS	NN	B-NP	O
,	,	,	O	O
ASA	ASA	NNP	B-NP	O
NICKOLAS	NICKOLAS	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
CODE	CODE	NNP	I-NP	O
STATUS	STATUS	NNP	I-NP	O
:	:	:	O	O
Full	Full	JJ	B-NP	O
code	code	NN	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Home	Home	NN	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
services	service	NNS	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
TYLENOL	TYLENOL	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
ACETAMINOPHEN	ACETAMINOPHEN	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
650	650	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
Q4H	Q4H	NNP	I-NP	O
PRN	PRN	NNP	I-NP	O
Headache	Headache	NNP	I-NP	O
ALBUTEROL	ALBUTEROL	NNP	I-NP	O
NEBULIZER	NEBULIZER	NNP	I-NP	O
2.5	2.5	CD	I-NP	O
MG	MG	NN	I-NP	O
NEB	NEB	NN	I-NP	O
Q4H	Q4H	NN	I-NP	O
PRN	PRN	NN	I-NP	O
Shortness	Shortness	NN	I-NP	O
of	of	IN	B-PP	O
Breath	Breath	NNP	B-NP	O
,	,	,	O	O
Wheezing	Wheezing	NNP	B-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
10/14/05	10/14/05	CD	B-NP	O
by	by	IN	B-PP	O
POITRAS	POITRAS	NN	B-NP	O
,	,	,	O	O
MICHAL	MICHAL	NNP	B-NP	O
M.	M.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
M.B.A.	M.B.A.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
NORTRIPTYLINE	NORTRIPTYLINE	NN	B-NP	O
HCL	HCL	NN	I-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
471480146	471480146	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ALBUTEROL	ALBUTEROL	NNP	B-NP	O
SULFATE	SULFATE	NNP	I-NP	O
&	&	CC	I-NP	O
NORTRIPTYLINE	NORTRIPTYLINE	NNP	I-NP	O
HCL	HCL	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
home	home	NN	B-NP	O
med	me	VBD	B-VP	O
TEGRETOL	TEGRETOL	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
CARBAMAZEPINE	CARBAMAZEPINE	NN	I-NP	O
-RRB-	-RRB-	HYPH	B-NP	O
400	400	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
10a	10a	NN	I-NP	O
,	,	,	O	O
2p	2p	NN	B-NP	O
,	,	,	O	O
8p	8p	NN	B-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Avoid	Avoid	NNP	I-NP	O
grapefruit	grapefruit	NN	I-NP	O
unless	unless	IN	B-SBAR	O
MD	MD	NN	B-NP	B-DNA
instructs	instruct	NNS	I-NP	I-DNA
otherwise	otherwise	RB	B-ADVP	O
.	.	.	O	O

Give	Give	VB	B-VP	O
with	with	IN	B-PP	O
meals	meal	NNS	B-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	B-ADJP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
10/14/05	10/14/05	CD	B-NP	O
by	by	IN	B-PP	O
BERMEA	BERMEA	NNP	B-NP	O
,	,	,	O	O
FLORENCIO	FLORENCIO	NNP	B-NP	O
J.	J.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
M.B.A.	M.B.A.	NNP	B-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
AZITHROMYCIN	AZITHROMYCIN	NNP	B-NP	O
&	&	CC	I-NP	O
CARBAMAZEPINE	CARBAMAZEPINE	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
home	home	NN	B-NP	O
med	me	VBD	B-VP	O
CLONAZEPAM	CLONAZEPAM	NN	B-NP	O
0.25	0.25	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
10a	10a	NN	I-NP	O
,	,	,	O	O
12p	12p	NN	B-NP	O
,	,	,	O	O
2p	2p	NN	B-NP	O
,	,	,	O	O
5p	5p	NN	B-NP	O
,	,	,	O	O
7pm	7pm	NN	B-NP	O
10p	10p	NN	I-NP	O
Starting	Starting	NNP	I-NP	O
Today	Today	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
4/9	4/9	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
10/14/05	10/14/05	CD	B-NP	O
by	by	IN	B-PP	O
PEREY	PEREY	NNP	B-NP	O
,	,	,	O	O
DONTE	DONTE	NNP	B-NP	O
M.	M.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
M.B.A.	M.B.A.	NNP	B-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
AZITHROMYCIN	AZITHROMYCIN	NNP	B-NP	O
&	&	CC	I-NP	O
CLONAZEPAM	CLONAZEPAM	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
home	home	NN	B-NP	O
med	me	VBD	B-VP	O
ATROVENT	ATROVENT	NN	B-NP	O
INHALER	INHALER	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
IPRATROPIUM	IPRATROPIUM	NN	I-NP	O
INHALER	INHALER	NN	I-NP	O
-RRB-	-RRB-	HYPH	B-NP	O
2	2	CD	I-NP	O
PUFF	PUFF	NN	I-NP	O
INH	INH	NNP	I-NP	O
QID	QID	NNP	I-NP	O
LISINOPRIL	LISINOPRIL	NNP	I-NP	O
40	40	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
10/19/05	10/19/05	CD	B-NP	O
by	by	IN	B-PP	O
ORILLION	ORILLION	NNP	B-NP	O
,	,	,	O	O
ELDON	ELDON	NNP	B-NP	O
M.	M.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
PH.D.	PH.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
KCL	KCL	NN	B-NP	O
IV	IV	CD	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
972201526	972201526	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LISINOPRIL	LISINOPRIL	NNP	B-NP	O
&	&	CC	I-NP	O
POTASSIUM	POTASSIUM	NNP	I-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
needs	need	VBZ	B-VP	O
Previous	Previous	JJ	B-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
10/14/05	10/14/05	CD	B-NP	O
by	by	IN	B-PP	O
TAVOLARIO	TAVOLARIO	NN	B-NP	B-protein
,	,	,	O	O
WILBER	WILBER	NNP	B-NP	O
M.	M.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
M.B.A.	M.B.A.	NNP	B-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
POTASSIUM	POTASSIUM	NNP	B-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
&	&	CC	I-NP	O
LISINOPRIL	LISINOPRIL	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
POTASSIUM	POTASSIUM	NNP	B-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
&	&	CC	I-NP	O
LISINOPRIL	LISINOPRIL	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
home	home	NN	B-NP	O
med	me	VBD	B-VP	O
LOPRESSOR	LOPRESSOR	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
METOPROLOL	METOPROLOL	NN	I-NP	O
TARTRATE	TARTRATE	NN	I-NP	O
-RRB-	-RRB-	HYPH	O	O
75	75	CD	B-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QID	QID	NNP	I-NP	O
HOLD	HOLD	NNP	I-NP	O
IF	IF	NNP	I-NP	O
:	:	:	O	O
sbp	sbp	NN	B-NP	O
<	<	SYM	O	O
90	90	CD	B-NP	O
,	,	,	O	O
HR	HR	NN	B-NP	O
<	<	SYM	O	O
55	55	CD	B-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Take	Take	NNP	I-NP	O
consistently	consistently	RB	B-ADVP	O
with	with	IN	B-PP	O
meals	meal	NNS	B-NP	O
or	or	CC	B-PP	O
on	on	IN	B-PP	O
empty	empty	JJ	B-NP	O
stomach	stomach	NN	I-NP	O
.	.	.	O	O

NORTRIPTYLINE	NORTRIPTYLINE	NN	B-NP	O
HCL	HCL	NN	I-NP	O
150	150	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
HS	HS	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
10/14/05	10/14/05	CD	B-NP	O
by	by	IN	B-PP	O
MCKEE	MCKEE	NNP	B-NP	O
,	,	,	O	O
CLIFF	CLIFF	NNP	B-NP	O
S.	S.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
M.B.A.	M.B.A.	NNP	B-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ALBUTEROL	ALBUTEROL	NNP	B-NP	O
SULFATE	SULFATE	NNP	I-NP	O
&	&	CC	I-NP	O
NORTRIPTYLINE	NORTRIPTYLINE	NNP	I-NP	O
HCL	HCL	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ALBUTEROL	ALBUTEROL	NNP	B-NP	O
SULFATE	SULFATE	NNP	I-NP	O
&	&	CC	I-NP	O
NORTRIPTYLINE	NORTRIPTYLINE	NNP	I-NP	O
HCL	HCL	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
home	home	NN	B-NP	B-RNA
med	me	VBD	B-VP	I-RNA
PHENERGAN	PHENERGAN	NN	B-NP	I-RNA
-LRB-	-LRB-	NN	I-NP	I-RNA
PROMETHAZINE	PROMETHAZINE	NN	I-NP	I-RNA
HCL	HCL	NN	I-NP	I-RNA
-RRB-	-RRB-	NN	I-NP	I-RNA
25	25	CD	I-NP	I-RNA
MG	MG	NNP	I-NP	I-RNA
PO	PO	NNP	I-NP	I-RNA
QID	QID	NNP	I-NP	I-RNA
SARNA	SARNA	NNP	I-NP	I-RNA
TOPICAL	TOPICAL	NNP	I-NP	O
TP	TP	NN	I-NP	O
BID	BID	NN	I-NP	O
Instructions	Instruction	NNS	I-NP	O
:	:	:	O	O
to	to	TO	B-PP	O
affected	affect	VBN	B-NP	O
area	area	NN	I-NP	O
COUMADIN	COUMADIN	NN	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
SODIUM	SODIUM	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
6.5	6.5	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QPM	QPM	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
ROUTINE	ROUTINE	NNP	I-NP	O
,	,	,	O	O
20	20	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
Standard	Standard	NNP	I-NP	O
Admin	Admin	NNP	I-NP	O
Time	Time	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Instructions	Instruction	NNPS	I-NP	O
:	:	:	O	O
take	take	VB	B-VP	O
6.5	6.5	CD	B-NP	O
mg	mg	NN	I-NP	O
on	on	IN	B-PP	O
sunday	sunday	NN	B-NP	O
night	night	NN	I-NP	O
1/3	1/3	CD	I-NP	O
,	,	,	O	O
on	on	IN	B-PP	O
monday	monday	NN	B-NP	O
4/9	4/9	CD	I-NP	O
,	,	,	O	O
on	on	IN	B-PP	O
tuesday	tuesday	NN	B-NP	O
4/9	4/9	CD	I-NP	O
and	and	CC	O	O
then	then	RB	B-VP	O
await	await	VBP	I-VP	O
INR	INR	NN	B-NP	O
results	result	NNS	I-NP	O
for	for	IN	B-PP	O
wednesday	wednesday	NN	B-NP	O
dose	dose	NN	I-NP	O
Food/Drug	Food/Drug	NN	I-NP	O
Interaction	Interaction	NN	I-NP	O
Instruction	Instruction	NN	I-NP	O
No	No	DT	B-NP	O
high	high	JJ	I-NP	O
Vitamin-K	Vitamin-K	NN	I-NP	O
containing	contain	VBG	B-VP	O
foods	food	NNS	B-NP	O
Alert	Alert	NNP	B-NP	O
overridden	overridden	JJ	B-ADJP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
10/14/05	10/14/05	CD	B-NP	O
by	by	IN	B-PP	O
GRAAP	GRAAP	NNP	B-NP	B-protein
,	,	,	O	O
JAMES	JAMES	NNP	B-NP	O
A.	A.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
M.B.A.	M.B.A.	NNP	B-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
AZITHROMYCIN	AZITHROMYCIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
SIMVASTATIN	SIMVASTATIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
home	home	NN	B-NP	O
med	me	VBD	B-VP	O
AZITHROMYCIN	AZITHROMYCIN	NNP	B-NP	O
250	250	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
Today	Today	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
4/9	4/9	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Instructions	Instruction	NNPS	I-NP	O
:	:	:	O	O
dose	dose	NN	B-NP	O
ending	end	VBG	B-VP	O
on	on	IN	B-PP	O
4/26/05	4/26/05	CD	B-NP	O
Food/Drug	Food/Drug	NN	I-NP	O
Interaction	Interaction	NN	I-NP	O
Instruction	Instruction	NN	I-NP	O
Avoid	Avoid	JJ	I-NP	O
antacids	antacid	NNS	I-NP	O
Take	Take	VBP	B-VP	O
with	with	IN	B-PP	O
food	food	NN	B-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
10/14/05	10/14/05	CD	B-NP	O
by	by	IN	B-PP	O
ZUMBO	ZUMBO	NNP	B-NP	B-protein
,	,	,	O	O
ROMAN	ROMAN	NNP	B-NP	O
E.	E.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
M.B.A.	M.B.A.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
TEMAZEPAM	TEMAZEPAM	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
693999571	693999571	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
AZITHROMYCIN	AZITHROMYCIN	NNP	B-NP	O
&	&	CC	I-NP	O
TEMAZEPAM	TEMAZEPAM	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
home	home	NN	B-NP	O
med	me	VBD	B-VP	O
Previous	Previous	JJ	B-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
10/14/05	10/14/05	CD	B-NP	O
by	by	IN	B-PP	O
QADEER	QADEER	NNP	B-NP	O
,	,	,	O	O
JERROD	JERROD	NNP	B-NP	O
C.	C.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
M.B.A.	M.B.A.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
TEGRETOL	TEGRETOL	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
703314616	703314616	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
AZITHROMYCIN	AZITHROMYCIN	NNP	B-NP	O
&	&	CC	I-NP	O
CARBAMAZEPINE	CARBAMAZEPINE	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
home	home	NN	B-NP	O
med	me	VBD	B-VP	O
Previous	Previous	JJ	B-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
10/14/05	10/14/05	CD	B-NP	O
by	by	IN	B-PP	O
VBILES	VBILES	NNP	B-NP	O
,	,	,	O	O
PATRICIA	PATRICIA	NNP	B-NP	O
J.	J.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
M.B.A.	M.B.A.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
COUMADIN	COUMADIN	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
035485948	035485948	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
AZITHROMYCIN	AZITHROMYCIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
home	home	NN	B-NP	O
med	me	VBD	B-VP	O
Previous	Previous	JJ	B-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
10/14/05	10/14/05	CD	B-NP	O
by	by	IN	B-PP	O
DYS	DYS	NNP	B-NP	O
,	,	,	O	O
JAMIE	JAMIE	NNP	B-NP	O
R.	R.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
M.B.A.	M.B.A.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
ZOCOR	ZOCOR	NN	B-NP	B-protein
PO	PO	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
ref	ref	NN	I-NP	I-protein
#	#	#	B-NP	I-protein
259319413	259319413	CD	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
AZITHROMYCIN	AZITHROMYCIN	NNP	B-NP	O
&	&	CC	I-NP	O
SIMVASTATIN	SIMVASTATIN	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
AZITHROMYCIN	AZITHROMYCIN	NNP	B-NP	O
&	&	CC	I-NP	O
SIMVASTATIN	SIMVASTATIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
home	home	NN	B-NP	O
med	me	VBD	B-VP	O
Previous	Previous	JJ	B-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
10/14/05	10/14/05	CD	B-NP	O
by	by	IN	B-PP	O
KEAMO	KEAMO	NN	B-NP	B-protein
,	,	,	O	O
ARLEN	ARLEN	NNP	B-NP	O
R.	R.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
M.B.A.	M.B.A.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
CLONAZEPAM	CLONAZEPAM	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
759318956	759318956	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
AZITHROMYCIN	AZITHROMYCIN	NNP	B-NP	O
&	&	CC	I-NP	O
CLONAZEPAM	CLONAZEPAM	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
home	home	NN	B-NP	O
med	me	VBD	B-VP	O
Previous	Previous	JJ	B-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
10/14/05	10/14/05	CD	B-NP	O
by	by	IN	B-PP	O
VANDERLOO	VANDERLOO	NNP	B-NP	O
,	,	,	O	O
JUSTIN	JUSTIN	NNP	B-NP	O
L.	L.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
M.B.A.	M.B.A.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
AZITHROMYCIN	AZITHROMYCIN	NNP	B-NP	O
PO	PO	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
522511231	522511231	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
Pt	Pt	NN	I-NP	O
.	.	.	O	O

has	have	VBZ	O	O
a	a	DT	B-NP	O
PROBABLE	PROBABLE	NN	I-NP	O
allergy	allergy	NN	I-NP	O
to	to	TO	B-PP	O
Erythromycins	Erythromycin	NNS	B-NP	O
;	;	:	O	O
reaction	reaction	NN	B-NP	O
is	be	VBZ	B-VP	O
GI	GI	NNP	B-NP	O
Intolerance	Intolerance	NNP	I-NP	O
.	.	.	O	O

Reason	Reason	NN	B-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
pt	pt	NN	B-NP	O
tolerates	tolerate	VBZ	B-VP	O
ZOCOR	ZOCOR	NN	B-NP	B-DNA
-LRB-	-LRB-	NN	I-NP	I-DNA
SIMVASTATIN	SIMVASTATIN	NN	I-NP	I-DNA
-RRB-	-RRB-	NN	I-NP	I-DNA
20	20	CD	I-NP	I-DNA
MG	MG	NNP	I-NP	I-DNA
PO	PO	NNP	I-NP	I-DNA
QHS	QHS	NNP	I-NP	I-DNA
Food/Drug	Food/Drug	NNP	I-NP	I-DNA
Interaction	Interaction	NNP	I-NP	I-DNA
Instruction	Instruction	NNP	I-NP	I-DNA
Avoid	Avoid	NNP	I-NP	I-DNA
grapefruit	grapefruit	NN	I-NP	I-DNA
unless	unless	IN	B-SBAR	I-DNA
MD	MD	NN	B-NP	I-DNA
instructs	instruct	NNS	I-NP	I-DNA
otherwise	otherwise	RB	B-ADVP	O
.	.	.	O	O

Override	Override	NNP	B-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
10/14/05	10/14/05	CD	B-NP	O
by	by	IN	B-PP	O
NAGATA	NAGATA	NNP	B-NP	O
,	,	,	O	O
IGNACIO	IGNACIO	NNP	B-NP	O
L.	L.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
M.B.A.	M.B.A.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
COUMADIN	COUMADIN	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
035485948	035485948	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
SIMVASTATIN	SIMVASTATIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
home	home	NN	B-NP	O
med	me	VBD	B-VP	O
Previous	Previous	JJ	B-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
10/14/05	10/14/05	CD	B-NP	O
by	by	IN	B-PP	O
PELOW	PELOW	NNP	B-NP	O
,	,	,	O	O
SCOTTIE	SCOTTIE	NNP	B-NP	O
W.	W.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
M.B.A.	M.B.A.	NNP	B-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
AZITHROMYCIN	AZITHROMYCIN	NNP	B-NP	O
&	&	CC	I-NP	O
SIMVASTATIN	SIMVASTATIN	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
AZITHROMYCIN	AZITHROMYCIN	NNP	B-NP	O
&	&	CC	I-NP	O
SIMVASTATIN	SIMVASTATIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
home	home	NN	B-NP	O
med	me	VBD	B-VP	O
VICODIN	VICODIN	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
HYDROCODONE	HYDROCODONE	NN	I-NP	O
5	5	CD	I-NP	O
MG	MG	NN	I-NP	O
+	+	SYM	B-NP	O
APAP	APAP	NN	I-NP	B-protein
-RRB-	-RRB-	SYM	B-NP	O
1	1	CD	I-NP	O
TAB	TAB	NN	I-NP	O
PO	PO	NN	I-NP	O
Q8H	Q8H	NN	I-NP	O
PRN	PRN	NN	I-NP	O
Pain	Pain	NNP	I-NP	O
Instructions	Instructions	NNP	I-NP	O
:	:	:	O	O
give	give	VB	B-VP	O
only	only	RB	B-SBAR	O
if	if	IN	I-SBAR	O
backpain	backpain	JJ	B-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
10/19/05	10/19/05	CD	B-NP	O
by	by	IN	B-PP	O
KRINGS	KRINGS	NNP	B-NP	O
,	,	,	O	O
LINO	LINO	NNP	B-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
VICODIN	VICODIN	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
817610686	817610686	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
Pt	Pt	NN	I-NP	O
.	.	.	O	O

has	have	VBZ	O	O
a	a	DT	B-NP	O
PROBABLE	PROBABLE	NN	I-NP	O
allergy	allergy	NN	I-NP	O
to	to	TO	B-PP	O
Codeine	Codeine	NN	B-NP	O
;	;	:	O	O
reactions	reaction	NNS	B-NP	O
are	be	VBP	B-VP	O
nausea	nausea	NN	B-NP	O
,	,	,	O	O
vomiting	vomiting	NN	B-NP	O
.	.	.	O	O

Reason	Reason	NN	B-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
patient	patient	NN	B-NP	O
takes	take	VBZ	B-VP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
rxn	rxn	NN	I-NP	B-protein
TESSALON	TESSALON	NN	I-NP	I-protein
PERLES	PERLES	NNP	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
BENZONATATE	BENZONATATE	NNP	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
100	100	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
TID	TID	NNP	I-NP	O
PRN	PRN	NNP	I-NP	O
Other	Other	NNP	I-NP	O
:	:	:	O	O
cough	cough	IN	B-PP	O
Number	Number	NNP	B-NP	O
of	of	IN	B-PP	O
Doses	Doses	NNP	B-NP	O
Required	Required	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
10	10	CD	B-NP	O
K-DUR	K-DUR	NN	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
KCL	KCL	NNP	I-NP	O
SLOW	SLOW	NNP	I-NP	O
RELEASE	RELEASE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
20	20	CD	I-NP	O
MEQ	MEQ	NN	I-NP	O
PO	PO	NN	I-NP	O
QD	QD	NN	I-NP	O
As	As	IN	B-PP	O
per	per	IN	B-PP	O
MCH	MCH	NNP	B-NP	O
Potassium	Potassium	NNP	I-NP	O
Chloride	Chloride	NNP	I-NP	O
Policy	Policy	NNP	I-NP	O
:	:	:	O	O
each	each	DT	B-NP	O
20	20	CD	I-NP	O
mEq	mEq	NN	I-NP	O
dose	dose	NN	I-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
given	give	VBN	I-VP	O
with	with	IN	B-PP	O
4	4	CD	B-NP	O
oz	oz	NN	I-NP	O
of	of	IN	B-PP	O
fluid	fluid	NN	B-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
10/14/05	10/14/05	CD	B-NP	O
by	by	IN	B-PP	O
MESHELL	MESHELL	NNP	B-NP	O
,	,	,	O	O
LYNN	LYNN	NNP	B-NP	O
E.	E.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
M.B.A.	M.B.A.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
LISINOPRIL	LISINOPRIL	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
241590083	241590083	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
POTASSIUM	POTASSIUM	NNP	B-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
&	&	CC	I-NP	O
LISINOPRIL	LISINOPRIL	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
home	home	NN	B-NP	O
med	me	VBD	B-VP	O
ZYRTEC	ZYRTEC	NN	B-NP	B-DNA
-LRB-	-LRB-	NNP	I-NP	I-DNA
CETIRIZINE	CETIRIZINE	NNP	I-NP	I-DNA
-RRB-	-RRB-	NNP	I-NP	I-DNA
10	10	CD	I-NP	I-DNA
MG	MG	NNP	I-NP	I-DNA
PO	PO	NNP	I-NP	I-DNA
BID	BID	NNP	I-NP	I-DNA
Starting	Starting	NNP	I-NP	I-DNA
Today	Today	NNP	I-NP	I-DNA
-LRB-	-LRB-	NNP	I-NP	I-DNA
4/9	4/9	CD	I-NP	I-DNA
-RRB-	-RRB-	NNP	I-NP	I-DNA
Food/Drug	Food/Drug	NNP	I-NP	I-DNA
Interaction	Interaction	NNP	I-NP	I-DNA
Instruction	Instruction	NNP	I-NP	I-DNA
Avoid	Avoid	NNP	I-NP	I-DNA
grapefruit	grapefruit	NN	I-NP	I-DNA
unless	unless	IN	B-SBAR	I-DNA
MD	MD	NN	B-NP	I-DNA
instructs	instruct	NNS	I-NP	I-DNA
otherwise	otherwise	RB	B-ADVP	O
.	.	.	O	O

Number	Number	NN	B-NP	O
of	of	IN	B-PP	O
Doses	Dose	NNS	B-NP	O
Required	Require	VBN	B-VP	O
-LRB-	-LRB-	HYPH	B-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
2	2	CD	B-NP	O
ADVAIR	ADVAIR	NN	I-NP	O
DISKUS	DISKUS	IN	B-PP	O
500/50	500/50	CD	B-NP	O
-LRB-	-LRB-	SYM	I-NP	O
FLUTICASONE	FLUTICASONE	NN	I-NP	O
PROPIONATE	PROPIONATE	NN	I-NP	O
/	/	SYM	B-NP	O
...	...	:	O	B-protein
-RRB-	-RRB-	SYM	B-NP	I-protein
1	1	CD	I-NP	I-protein
PUFF	PUFF	NN	I-NP	I-protein
INH	INH	NN	I-NP	I-protein
BID	BID	NN	I-NP	I-protein
GLYBURIDE	GLYBURIDE	NN	I-NP	I-protein
10	10	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
QD	QD	NN	I-NP	I-protein
LASIX	LASIX	NN	I-NP	I-protein
-LRB-	-LRB-	HYPH	B-NP	I-protein
FUROSEMIDE	FUROSEMIDE	NN	I-NP	I-protein
-RRB-	-RRB-	HYPH	I-NP	I-protein
40	40	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
QD	QD	NN	I-NP	I-protein
ZANTAC	ZANTAC	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
RANITIDINE	RANITIDINE	NN	I-NP	I-protein
HCL	HCL	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
150	150	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
BID	BID	NNP	I-NP	O
DIET	DIET	NNP	I-NP	O
:	:	:	O	O
House	House	NNP	B-NP	O
/	/	SYM	B-NP	O
Low	Low	JJ	I-NP	O
chol/low	chol/low	NN	I-NP	O
sat	sat	NN	I-NP	O
.	.	.	O	O

fat	fat	JJ	B-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
House	House	NN	B-NP	O
/	/	SYM	O	O
ADA	ADA	NN	B-NP	O
2100	2100	CD	I-NP	O
cals/dy	cals/dy	NN	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
4	4	CD	B-NP	O
gram	gram	NN	I-NP	O
Sodium	Sodium	NN	I-NP	O
ACTIVITY	ACTIVITY	NN	I-NP	O
:	:	:	O	O
Walking	Walk	VBG	B-VP	O
as	as	IN	B-SBAR	O
tolerated	tolerate	VBN	B-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
Dr.	Dr.	NNP	B-NP	O
Boccia	Boccia	NNP	I-NP	O
1-2	1-2	NN	I-NP	O
weeks	week	NNS	I-NP	O
,	,	,	O	O
Endocrine	Endocrine	NNP	B-NP	O
Clinic	Clinic	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
please	please	VB	B-VP	O
call	call	NN	B-NP	B-protein
837-578-9683	837-578-9683	CD	I-NP	I-protein
-RRB-	-RRB-	HYPH	B-NP	I-protein
2-4	2-4	CD	I-NP	I-protein
weeks	week	NNS	I-NP	I-protein
,	,	,	O	O
Opthamology	Opthamology	NN	B-NP	B-protein
2-4	2-4	CD	B-NP	I-protein
weeks	week	NNS	I-NP	I-protein
,	,	,	O	O
Podiatry	Podiatry	NN	B-NP	B-protein
1	1	CD	I-NP	I-protein
week	week	NN	I-NP	I-protein
,	,	,	O	O
Arrange	Arrange	NNP	B-NP	O
INR	INR	NNP	I-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
drawn	draw	VBN	I-VP	O
on	on	IN	B-PP	O
4/26/05	4/26/05	CD	B-NP	O
with	with	IN	B-PP	O
f/u	f/u	NN	B-NP	O
INR	INR	NNP	B-NP	O
's	's	POS	B-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
drawn	draw	VBN	I-VP	O
every	every	DT	B-NP	O
3	3	CD	I-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

INR	INR	NN	B-NP	O
's	's	POS	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
followed	follow	VBN	I-VP	O
by	by	IN	B-PP	O
Coumadin	Coumadin	NNP	B-NP	O
Clinic	Clinic	NNP	I-NP	O
ALLERGY	ALLERGY	NNP	I-NP	O
:	:	:	O	O
IV	IV	CD	B-NP	O
Contrast	Contrast	NN	I-NP	O
,	,	,	O	O
Penicillins	Penicillins	NNP	B-NP	O
,	,	,	O	O
Shellfish	Shellfish	NNP	B-NP	O
,	,	,	O	O
NARCOTICS	NARCOTICS	NNP	B-NP	O
,	,	,	O	O
PHENANTHRENES	PHENANTHRENES	NNP	B-NP	O
,	,	,	O	O
Bee	Bee	NNP	B-NP	O
Stings	Stings	NNP	I-NP	O
,	,	,	O	O
LEVOFLOXACIN	LEVOFLOXACIN	NNP	B-NP	O
,	,	,	O	O
Cephalosporins	Cephalosporins	NNP	B-NP	O
,	,	,	O	O
BETADINE/IODINE	BETADINE/IODINE	NNP	B-NP	O
ADMIT	ADMIT	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
:	:	:	O	O
CHF	CHF	NN	B-NP	O
exacerbation	exacerbation	NN	I-NP	O
,	,	,	O	O
cellulitis	cellulitis	NN	B-NP	O
PRINCIPAL	PRINCIPAL	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NNP	B-NP	O
for	for	IN	B-PP	O
Causing	Causing	NNP	B-NP	O
Admission	Admission	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
CHF	CHF	NNP	I-NP	O
exacerbation	exacerbation	NN	I-NP	O
,	,	,	O	O
cellulitis	cellulitis	NN	B-NP	O
OTHER	OTHER	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
HTN	HTN	NN	I-NP	O
FIBROMYALGIA	FIBROMYALGIA	NN	I-NP	O
SEVERE	SEVERE	NN	I-NP	O
OA	OA	NN	I-NP	O
OF	OF	IN	B-PP	O
R	R	NN	B-NP	O
KNEE	KNEE	NN	I-NP	O
MIGRAINES	MIGRAINES	NN	I-NP	O
H/O	H/O	NN	I-NP	O
LARGE	LARGE	NN	I-NP	O
GALL	GALL	NN	I-NP	O
STONE	STONE	NN	I-NP	O
H/O	H/O	NN	I-NP	O
DVT	DVT	NN	I-NP	O
IN	IN	NN	I-NP	O
RLE	RLE	NN	I-NP	O
s/p	s/p	NN	I-NP	O
CABG	CABG	NN	I-NP	O
'96	'96	CD	I-NP	O
s/p	s/p	NN	I-NP	O
st	st	NN	I-NP	O
Jude	Jude	NNP	I-NP	O
MVR	MVR	NNP	I-NP	B-cell_line
'96	'96	POS	B-NP	I-cell_line
OPERATIONS	OPERATIONS	NNPS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNPS	I-NP	O
:	:	:	O	O
NONE	NONE	NN	B-NP	O
OTHER	OTHER	NN	I-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
See	See	NNP	I-NP	O
DC	DC	NNP	I-NP	B-cell_type
Summ	Summ	NNP	I-NP	O
BRIEF	BRIEF	NNP	I-NP	O
RESUME	RESUME	NNP	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	NNP	B-NP	O
COURSE	COURSE	NNP	I-NP	O
:	:	:	O	O
CC	CC	NN	B-NP	O
:	:	:	O	O
Right	Right	NN	B-NP	O
toe/leg	toe/leg	NN	I-NP	O
swelling	swelling	NN	I-NP	O
,	,	,	O	O
cough	cough	NN	B-NP	O
*******************	*******************	SYM	B-NP	O
HPI	HPI	NN	I-NP	O
:	:	:	O	O
60F	60F	NN	B-NP	O
COPD	COPD	NN	I-NP	O
,	,	,	O	O
pulm	pulm	NN	B-NP	O
HTN	HTN	NN	I-NP	O
and	and	CC	I-NP	O
pass	pass	NN	I-NP	O
admissions	admission	NNS	I-NP	O
for	for	IN	B-PP	O
volume	volume	NN	B-NP	B-DNA
overload	overload	NN	I-NP	I-DNA
adn	adn	NN	I-NP	I-DNA
COPD	COPD	NN	I-NP	I-DNA
flares	flare	NNS	I-NP	I-DNA
who	who	WP	B-NP	O
5	5	CD	B-NP	O
days	day	NNS	I-NP	O
ago	ago	RB	B-ADVP	O
developed	develop	VBD	B-VP	O
initial	initial	JJ	B-NP	O
sneezing	sneezing	NN	I-NP	O
and	and	CC	I-NP	O
water	water	NN	I-NP	O
eyes	eye	NNS	I-NP	O
following	follow	VBG	B-PP	O
cough	cough	NN	B-NP	O
productive	productive	JJ	B-ADJP	O
of	of	IN	B-PP	O
yellow	yellow	JJ	B-NP	O
sputum	sputum	NN	I-NP	O
,	,	,	O	O
SOB	SOB	NN	B-NP	B-protein
,	,	,	O	O
sinus	sinus	NN	B-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
purulent	purulent	JJ	B-NP	O
nasal	nasal	JJ	I-NP	O
drainage	drainage	NN	I-NP	O
.	.	.	O	O

Denies	Deny	NNS	B-NP	O
anys	any	VBZ	B-VP	O
ore	ore	NN	B-NP	O
throat	throat	NN	I-NP	O
,	,	,	O	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
abdominal	abdominal	JJ	B-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
diarrhea	diarrhea	NN	B-NP	O
,	,	,	O	O
blood	blood	NN	B-NP	O
in	in	IN	B-PP	O
stool	stool	NN	B-NP	O
,	,	,	O	O
dysuria	dysuria	NN	B-NP	O
,	,	,	O	O
rash	rash	NN	B-NP	O
,	,	,	O	O
joint	joint	JJ	B-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
orthopnea	orthopnea	NN	B-NP	O
.	.	.	O	O

SOB	SOB	NN	B-NP	B-protein
and	and	CC	O	O
wheezing	wheeze	VBG	B-VP	O
requriing	requrie	VBG	I-VP	O
increased	increase	VBN	B-NP	O
neb	neb	NN	I-NP	O
treatments	treatment	NNS	I-NP	O
over	over	IN	B-PP	O
last	last	JJ	B-NP	O
few	few	JJ	I-NP	O
days	day	NNS	I-NP	O
-LRB-	-LRB-	SYM	B-NP	O
1	1	CD	I-NP	O
to	to	TO	B-PP	O
2	2	CD	B-NP	O
up	up	RP	B-PRT	O
until	until	IN	B-PP	O
4-5	4-5	NN	B-NP	O
/	/	SYM	B-NP	O
day	day	NN	I-NP	O
-RRB-	-RRB-	SYM	B-ADJP	O
and	and	CC	O	O
waking	wake	VBG	B-VP	O
up	up	RP	B-PRT	O
@	@	NN	B-NP	O
night	night	NN	I-NP	O
with	with	IN	B-PP	O
SOB	SOB	NN	B-NP	B-protein
.	.	.	O	O

Yesterday	Yesterday	NN	B-NP	O
her	her	PRP$	B-NP	O
daughter	daughter	NN	I-NP	O
noticed	notice	VBD	B-VP	O
a	a	DT	B-NP	O
region	region	NN	I-NP	O
of	of	IN	B-PP	O
erythema	erythema	NN	B-NP	O
on	on	IN	B-PP	O
distal	distal	JJ	B-NP	O
aspect	aspect	NN	I-NP	O
of	of	IN	B-PP	O
right	right	JJ	B-NP	O
2nd	2nd	JJ	I-NP	O
toe	toe	NN	I-NP	O
and	and	CC	I-NP	O
abrasion	abrasion	NN	I-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
baseline	baseline	NN	B-NP	O
,	,	,	O	O
pt	pt	NN	B-NP	O
has	have	VBZ	B-VP	O
DM	DM	NN	B-NP	O
neuropathy	neuropathy	NN	I-NP	O
affecting	affect	VBG	B-VP	O
distal	distal	JJ	B-NP	O
LE	LE	NN	I-NP	O
and	and	CC	O	O
has	have	VBZ	B-VP	O
decreased	decrease	VBN	I-VP	O
sensation	sensation	NN	B-NP	O
.	.	.	O	O

Denied	Denied	JJ	B-NP	O
pain	pain	NN	I-NP	O
and	and	CC	I-NP	O
swelling	swelling	NN	I-NP	O
in	in	IN	B-PP	O
lower	low	JJR	B-NP	O
ext	ext	NN	I-NP	O
and	and	CC	O	O
is	be	VBZ	B-VP	O
new	new	JJ	B-ADJP	O
.	.	.	O	O

Denied	Denied	JJ	B-NP	O
fevers	fever	NNS	I-NP	O
,	,	,	O	O
chills	chill	NNS	B-NP	O
,	,	,	O	O
nausea	nausea	NN	B-NP	O
,	,	,	O	O
vomitting	vomitting	NN	B-NP	O
,	,	,	O	O
sweats	sweat	NNS	B-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
ED	ED	NN	B-NP	O
,	,	,	O	O
VS	VS	NN	B-NP	B-protein
were	be	VBD	B-VP	I-protein
initially	initially	RB	B-NP	I-protein
normal	normal	JJ	I-NP	I-protein
inclduing	incldue	VBG	I-NP	I-protein
o2	o2	NN	I-NP	I-protein
sat	sit	VBD	B-VP	O
but	but	CC	O	O
was	be	VBD	B-VP	O
quite	quite	RB	B-ADJP	O
dyspenic	dyspenic	JJ	I-ADJP	O
and	and	CC	O	O
had	have	VBD	B-VP	O
low	low	JJ	B-NP	O
sat	sat	NN	I-NP	O
in	in	IN	B-PP	O
90s	90	NNS	B-NP	O
which	which	WDT	B-NP	O
improved	improve	VBD	B-VP	O
after	after	IN	B-PP	O
neb	neb	NN	B-NP	O
tx	tx	NN	I-NP	O
.	.	.	O	O

Recevied	Recevie	VBN	B-VP	O
lasix	lasix	CD	B-NP	O
40	40	CD	I-NP	O
IV	IV	CD	I-NP	O
and	and	CC	O	O
prednisone	prednisone	NN	B-NP	O
60mg	60mg	NN	I-NP	O
,	,	,	O	O
alb	alb	NN	B-NP	B-protein
and	and	CC	O	O
atrovent	atrovent	JJ	B-NP	O
nebs	neb	NNS	I-NP	O
,	,	,	O	O
azithromycin	azithromycin	NN	B-NP	O
500mg	500mg	CD	I-NP	O
nad	nad	NN	I-NP	O
clinda	clinda	NN	I-NP	O
600mg	600mg	NN	I-NP	O
,	,	,	O	O
tylenol	tylenol	NN	B-NP	O
and	and	CC	I-NP	O
tessalon	tessalon	NN	I-NP	O
.	.	.	O	O

*******************	*******************	SYM	B-NP	O
PMH	PMH	NN	I-NP	O
:	:	:	O	O
COPD	COPD	NN	B-NP	O
with	with	IN	B-PP	O
chest	chest	NN	B-NP	O
CT	CT	NN	I-NP	O
on	on	IN	B-PP	O
8/10	8/10	CD	B-NP	O
showing	show	VBG	I-NP	O
RLL	RLL	NN	I-NP	O
nodule	nodule	NN	I-NP	O
and	and	CC	O	O
air	air	NN	B-NP	O
trapping	trapping	NN	I-NP	O
,	,	,	O	O
pulm	pulm	NN	B-NP	O
htn	htn	NN	I-NP	O
,	,	,	O	O
cabg	cabg	NN	B-NP	B-protein
x	x	SYM	O	I-protein
2	2	CD	B-NP	I-protein
with	with	IN	B-PP	O
recent	recent	JJ	B-NP	O
admission	admission	NN	I-NP	O
CP	CP	NN	I-NP	O
in	in	IN	B-PP	O
6/8	6/8	CD	B-NP	O
with	with	IN	B-PP	O
neg	neg	NN	B-NP	O
PET	PET	NN	I-NP	O
stress	stress	NN	I-NP	O
,	,	,	O	O
DM	DM	NN	B-NP	O
,	,	,	O	O
post	post	NN	B-NP	O
MVR	MVR	NN	I-NP	O
with	with	IN	B-PP	O
mech	mech	NN	B-NP	O
valve	valve	VBP	B-VP	O
-LRB-	-LRB-	NN	B-NP	B-protein
STJ	STJ	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
on	on	IN	B-PP	O
AC	AC	NN	B-NP	O
1996	1996	CD	I-NP	O
,	,	,	O	O
Sjogren	Sjogren	NNP	B-NP	O
's	's	POS	B-NP	O
,	,	,	O	O
seizure	seizure	NN	B-NP	O
do	do	VBP	B-VP	O
,	,	,	O	O
depression	depression	NN	B-NP	O
,	,	,	O	O
h/o	h/o	NN	B-NP	O
dvt	dvt	NN	I-NP	O
RLE	RLE	NN	I-NP	O
,	,	,	O	O
rigt	rigt	NN	B-NP	O
TKR	TKR	NN	I-NP	O
*******************	*******************	SYM	B-NP	O
MEDS	MEDS	NN	I-NP	O
:	:	:	O	O
Tegretol	Tegretol	NN	B-NP	O
400	400	CD	I-NP	O
TID	TID	NN	I-NP	O
,	,	,	O	O
Klonipin	Klonipin	NN	B-NP	O
0.25	0.25	CD	I-NP	O
mg	mg	NN	I-NP	O
q2h	q2h	NN	I-NP	O
,	,	,	O	O
Atarax	Atarax	NN	B-NP	O
10mg	10mg	NN	I-NP	O
po	po	NN	I-NP	O
qid	qid	NN	I-NP	O
,	,	,	O	O
Lisinopril	Lisinopril	NNP	B-NP	O
60mg	60mg	NN	I-NP	O
po	po	NN	I-NP	O
qd	qd	NN	I-NP	O
,	,	,	O	O
lopressor	lopressor	NN	B-NP	O
75	75	CD	I-NP	O
,	,	,	I-NP	O
g	g	NN	I-NP	O
po	po	NN	I-NP	O
qid	qid	NN	I-NP	O
,	,	,	O	O
nortryptilline	nortryptilline	NN	B-NP	O
150mg	150mg	NN	I-NP	O
po	po	NN	I-NP	O
qhs	qh	NNS	I-NP	O
,	,	,	O	O
glyburide	glyburide	NN	B-NP	O
10mg	10mg	NN	I-NP	O
po	po	NN	I-NP	O
qd	qd	NN	I-NP	O
,	,	,	O	O
advair	advair	NN	B-NP	O
500/50	500/50	CD	I-NP	O
1puff	1puff	NN	I-NP	O
bid	bid	NN	I-NP	O
,	,	,	O	O
1-2	1-2	CD	B-NP	O
alb	alb	NN	I-NP	O
nebs	neb	NNS	I-NP	O
per	per	IN	B-PP	O
day	day	NN	B-NP	O
,	,	,	O	O
lasix	lasix	NN	B-NP	O
40mg	40mg	NN	I-NP	O
qd	qd	NN	I-NP	O
,	,	,	O	O
k-dur	k-dur	JJ	B-NP	O
20meq	20meq	NN	I-NP	O
qd	qd	NN	I-NP	O
,	,	,	O	O
zyrtec	zyrtec	NN	B-NP	O
10mg	10mg	NN	I-NP	O
po	po	NN	I-NP	O
bid	bid	NN	I-NP	O
,	,	,	O	O
vicodin	vicodin	NN	B-NP	O
1	1	CD	I-NP	O
tab	tab	NN	I-NP	O
po	po	NN	I-NP	O
q6h	q6h	NN	I-NP	O
,	,	,	O	O
zantac	zantac	NN	B-NP	O
150mg	150mg	NN	I-NP	O
po	po	NN	I-NP	O
bid	bid	NN	I-NP	O
,	,	,	O	O
zocor	zocor	NN	B-NP	O
20mg	20mg	NN	I-NP	O
po	po	NN	I-NP	O
qhs	qh	NNS	I-NP	O
,	,	,	O	O
coumadin	coumadin	NN	B-NP	O
6.5	6.5	CD	I-NP	O
mg	mg	NN	I-NP	O
po	po	NN	I-NP	O
qhs	qh	NNS	I-NP	O
,	,	,	O	O
celexa	celexa	NN	B-NP	O
10mg	10mg	NN	I-NP	O
po	po	NN	I-NP	O
qd	qd	NN	I-NP	O
,	,	,	O	O
phenergan	phenergan	NN	B-NP	O
20mg	20mg	NN	I-NP	O
po	po	NN	I-NP	O
qid	qid	NN	I-NP	O
*******************	*******************	SYM	B-NP	O
ALL	ALL	NN	I-NP	O
:	:	:	O	O
PCN	PCN	NN	B-NP	B-protein
,	,	,	O	O
iodine	iodine	NN	B-NP	O
*******************	*******************	SYM	I-NP	O
SH	SH	NN	I-NP	O
:	:	:	O	O
lives	life	NNS	B-NP	O
with	with	IN	B-PP	O
grandson	grandson	NN	B-NP	O
,	,	,	O	O
47	47	CD	B-NP	O
pack	pack	NN	I-NP	O
year	year	NN	I-NP	O
hx	hx	NN	I-NP	O
quit	quit	VBD	B-VP	O
today	today	NN	B-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
ETOH	ETOH	NN	I-NP	B-protein
,	,	,	O	O
divorced	divorce	VBD	B-VP	O
*******************	*******************	SYM	B-NP	O
EXAM	EXAM	NN	I-NP	O
@	@	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
:	:	:	O	O
T96	T96	NN	B-NP	O
.8	.8	CD	B-NP	O
P73	P73	NN	I-NP	O
136/59	136/59	CD	B-NP	O
R24	R24	NN	I-NP	O
96	96	CD	B-NP	O
%	%	NN	I-NP	O
RA	RA	NN	I-NP	O
Gen	Gen	NNP	I-NP	O
:	:	:	O	O
Well	Well	NNP	B-NP	O
appearing	appear	VBG	B-VP	O
,	,	,	O	O
breathing	breathe	VBG	B-VP	O
comfortably	comfortably	RB	B-NP	O
HEENT	HEENT	NN	I-NP	O
:	:	:	O	O
maxillary/frontal	maxillary/frontal	JJ	B-NP	O
sinus	sinus	NN	I-NP	O
tenderness	tenderness	NN	I-NP	O
,	,	,	O	O
clear	clear	JJ	B-NP	O
oropharynx	oropharynx	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
LAD	LAD	NNP	I-NP	O
Chest	Chest	NNP	I-NP	O
:	:	:	O	O
Wheezing	Wheezing	NNP	B-NP	O
intermittent	intermittent	JJ	I-NP	O
otherwise	otherwise	RB	I-NP	O
clear	clear	JJ	I-NP	O
CV	CV	NN	I-NP	O
:	:	:	O	O
RRR	RRR	NN	B-NP	B-protein
,	,	,	O	O
mechanical	mechanical	JJ	B-NP	O
S1	S1	NN	I-NP	O
,	,	,	O	O
I/VI	I/VI	NN	B-NP	B-protein
ejection	ejection	NN	I-NP	I-protein
murmur	murmur	NN	I-NP	I-protein
LSB	LSB	NNP	I-NP	I-protein
,	,	,	O	O
JVP	JVP	NNP	B-NP	O
10	10	CD	I-NP	O
Abd	Abd	NNP	I-NP	O
:	:	:	O	O
Obese	Obese	NNP	B-NP	O
,	,	,	O	O
NT	NT	NNP	B-NP	O
+	+	NNP	I-NP	O
BS	BS	NNP	I-NP	O
Ext	Ext	NNP	I-NP	O
:	:	:	O	O
improved	improve	VBN	B-NP	O
edema	edema	NN	I-NP	O
of	of	IN	B-PP	O
lower	low	JJR	B-NP	O
ext	ext	NN	I-NP	O
,	,	,	O	O
rigth	rigth	JJ	B-NP	O
2nd	2nd	NN	I-NP	O
toe	toe	NN	I-NP	O
abrasion	abrasion	NN	I-NP	O
of	of	IN	B-PP	O
sital	sital	JJ	B-NP	O
aspect	aspect	NN	I-NP	O
with	with	IN	B-PP	O
overlaying	overlay	VBG	B-VP	O
scab	scab	NN	B-NP	O
and	and	CC	O	O
surrounding	surround	VBG	B-VP	O
erythema	erythema	NN	B-NP	O
decreased	decrease	VBD	B-VP	O
swelling/stable	swelling/stable	JJ	B-ADJP	O
;	;	:	O	O
no	no	DT	B-NP	O
tenderness	tenderness	NN	I-NP	O
or	or	CC	I-NP	O
warmth	warmth	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
puss	puss	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
exudates	exudate	NNS	I-NP	O
*******************	*******************	SYM	B-NP	O
CXR	CXR	NN	I-NP	B-protein
:	:	:	O	O
no	no	DT	B-NP	O
acute	acute	JJ	I-NP	O
pulm/card	pulm/card	NN	I-NP	O
process	process	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
infiltrate	infiltrate	NN	I-NP	O
EKG	EKG	NN	I-NP	O
:	:	:	O	O
NSR	NSR	NN	B-NP	O
70s	70	NNS	I-NP	O
,	,	,	O	O
poor	poor	JJ	B-NP	O
RWP	RWP	NN	I-NP	O
,	,	,	O	O
ST	ST	NN	B-NP	O
seg	seg	NN	I-NP	O
normal	normal	JJ	I-NP	O
*******************	*******************	SYM	I-NP	O
HOSPITAL	HOSPITAL	JJ	I-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
60F	60F	NN	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
COPD	COPD	NN	B-NP	O
,	,	,	O	O
RHF	RHF	NN	B-NP	B-protein
,	,	,	O	O
with	with	IN	B-PP	O
history	history	NN	B-NP	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
sinusitis	sinusitis	NN	B-NP	O
,	,	,	O	O
bronchitis	bronchitis	NN	B-NP	O
with	with	IN	B-PP	O
related	related	JJ	B-NP	O
COPD	COPD	NN	I-NP	O
exacerbation	exacerbation	NN	I-NP	O
appearing	appear	VBG	B-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
beginnings	beginning	NNS	B-NP	O
of	of	IN	B-PP	O
celulitis	celulitis	NN	B-NP	O
on	on	IN	B-PP	O
RLE	RLE	NN	B-NP	B-protein
.	.	.	O	O

1	1	LS	B-LST	O
.	.	.	O	O

PULM	PULM	NN	B-NP	B-protein
-	-	HYPH	I-NP	O
Patient	Patient	NN	I-NP	O
when	when	WRB	B-ADVP	O
first	first	RB	B-VP	O
admitted	admit	VBN	I-VP	O
was	be	VBD	B-VP	O
slightly	slightly	RB	B-ADJP	O
dyspneic	dyspneic	JJ	I-ADJP	O
and	and	CC	O	O
had	have	VBD	B-VP	O
intermittent	intermittent	JJ	B-NP	O
wheezing	wheezing	NN	I-NP	O
.	.	.	O	O

Given	Give	VBN	B-NP	O
steroids	steroid	NNS	I-NP	O
-LRB-	-LRB-	-LRB	B-NP	B-protein
prednisone	prednisone	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
x	x	SYM	B-NP	I-protein
1	1	CD	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
in	in	IN	B-PP	O
ED	ED	NN	B-NP	O
.	.	.	O	O

Then	Then	RB	O	O
also	also	RB	B-ADVP	O
given	give	VBN	B-PP	O
nebs	neb	NNS	B-NP	O
with	with	IN	B-PP	O
rapid	rapid	JJ	B-NP	O
improvement	improvement	NN	I-NP	O
within	within	IN	B-PP	O
12	12	CD	B-NP	O
hours	hour	NNS	I-NP	O
.	.	.	O	O

Patient	Patient	NN	B-NP	O
then	then	RB	B-ADVP	O
continued	continue	VBD	B-VP	O
on	on	IN	B-PP	O
nebs	neb	NNS	B-NP	O
round	round	JJ	B-NP	O
clock	clock	NN	I-NP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
further	further	JJ	I-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
COPD	COPD	NN	B-NP	B-DNA
flare	flare	NN	I-NP	I-DNA
.	.	.	O	O

As	As	IN	B-PP	O
a	a	DT	B-NP	O
result	result	NN	I-NP	O
,	,	,	O	O
patient	patient	NN	B-NP	O
's	's	POS	B-NP	O
slight	slight	JJ	I-NP	O
SOB	SOB	NN	I-NP	O
likely	likely	RB	B-ADJP	O
due	due	IN	B-PP	O
to	to	TO	B-PP	O
slight	slight	JJ	B-NP	O
CHF	CHF	NN	I-NP	O
.	.	.	O	O

Continued	Continue	VBN	B-NP	O
diuresis	diuresis	NN	I-NP	O
.	.	.	O	O

Continued	Continue	VBN	B-NP	O
Azithro	Azithro	NN	I-NP	O
for	for	IN	B-PP	O
sinusitis	sinusitis	NN	B-NP	O
and	and	CC	I-NP	O
bronchitis/cough	bronchitis/cough	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

CV	CV	NN	B-NP	O
-	-	HYPH	I-NP	O
Patient	Patient	NN	I-NP	O
more	more	JJR	I-NP	O
likley	likley	NN	I-NP	O
to	to	TO	B-VP	O
have	have	VB	I-VP	O
slight	slight	JJ	B-NP	O
CHF	CHF	NN	I-NP	O
flare	flare	NN	I-NP	O
with	with	IN	B-PP	O
slight	slight	JJ	B-NP	O
LE	LE	NN	I-NP	O
edema	edema	NN	I-NP	O
.	.	.	O	O

Dry	Dry	NN	B-NP	O
weight	weight	NN	I-NP	O
104-105kg	104-105kg	NN	I-NP	O
and	and	CC	I-NP	O
pt	pt	NN	I-NP	O
had	have	VBD	B-VP	O
109.9	109.9	CD	B-NP	O
kg	kg	NN	I-NP	O
weight	weight	NN	I-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

Patient	Patient	NN	B-NP	O
was	be	VBD	B-VP	O
diuresed	diurese	VBN	I-VP	O
over	over	IN	B-PP	O
hospital	hospital	NN	B-NP	O
course	course	NN	I-NP	O
with	with	IN	B-PP	O
good	good	JJ	B-NP	O
result	result	NN	I-NP	O
.	.	.	O	O

Resuming	Resume	VBG	B-VP	O
home	home	NN	B-NP	O
BB	BB	NN	I-NP	O
+	+	SYM	B-NP	O
ACE	ACE	NN	I-NP	O
.	.	.	O	O

Patient	Patient	NN	B-NP	O
's	's	POS	B-NP	O
Na	Na	NN	I-NP	O
also	also	RB	B-ADVP	O
slowly	slowly	RB	B-VP	O
trended	trend	VBN	I-VP	O
up	up	IN	B-PRT	O
and	and	CC	O	O
initial	initial	JJ	B-NP	O
hyponatremia	hyponatremia	NN	I-NP	O
likely	likely	RB	B-ADJP	O
due	due	IN	B-PP	O
to	to	TO	I-PP	O
CHF	CHF	NN	B-NP	B-protein
.	.	.	O	O

Also	Also	RB	B-ADVP	O
placed	place	VBN	B-VP	O
on	on	IN	B-PP	O
fluid	fluid	NN	B-NP	O
restriction	restriction	NN	I-NP	O
,	,	,	O	O
daily	daily	JJ	B-NP	O
weights	weight	NNS	I-NP	O
,	,	,	O	O
strict	strict	JJ	B-NP	O
i/o	i/o	NN	I-NP	O
.	.	.	O	O

ISCH/RHYTHM-no	ISCH/RHYTHM-no	JJ	B-NP	O
active	active	JJ	I-NP	O
issues	issue	NNS	I-NP	O
during	during	IN	B-PP	O
this	this	DT	B-NP	O
hosp	hosp	NN	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

ID	ID	NN	B-NP	O
-	-	HYPH	I-NP	O
Azithro	Azithro	NN	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
sinusitis	sinusitis	NN	I-NP	B-protein
-RRB-	-RRB-	NN	I-NP	I-protein
+	+	SYM	B-NP	O
Clinda	Clinda	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
cellulitis	cellulitis	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
x	x	SYM	B-VP	O
7	7	CD	B-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

Vascular	Vascular	JJ	B-NP	O
surgery	surgery	NN	I-NP	O
consult	consult	NN	I-NP	O
called	call	VBN	B-VP	O
to	to	TO	B-VP	O
eval	eval	VB	I-VP	O
right	right	JJ	B-NP	O
2nd	2nd	NN	I-NP	O
toe	toe	NN	I-NP	O
and	and	CC	O	O
their	their	PRP$	B-NP	O
recommendation	recommendation	NN	I-NP	O
is	be	VBZ	B-VP	O
for	for	IN	B-PP	O
coverage	coverage	NN	B-NP	O
for	for	IN	B-PP	O
gram	gram	NN	B-NP	O
+	+	SYM	B-NP	O
x	x	SYM	B-VP	O
7	7	CD	B-NP	O
days	day	NNS	I-NP	O
and	and	CC	O	O
agreed	agree	VBD	B-VP	O
with	with	IN	B-PP	O
clinda	clinda	NN	B-NP	O
.	.	.	O	O

Close	Close	JJ	B-NP	O
f/u	f/u	NN	I-NP	O
with	with	IN	B-PP	O
podiatry	podiatry	NN	B-NP	O
as	as	IN	B-PP	O
outpt	outpt	NN	B-NP	O
.	.	.	O	O

Patient	Patient	NN	B-NP	O
dc	dc	NN	I-NP	O
'd	'd	VBD	B-VP	O
on	on	IN	B-PP	O
clinda	clinda	NN	B-NP	O
due	due	JJ	B-ADJP	O
to	to	TO	B-PP	O
gi	gi	NN	B-NP	O
intolerance	intolerance	NN	I-NP	O
but	but	CC	O	O
will	will	MD	B-VP	O
complete	complete	VB	I-VP	O
azithro	azithro	NN	B-NP	O
as	as	IN	B-PP	O
outpt	outpt	NN	B-NP	O
.	.	.	O	O

Vascular	Vascular	JJ	B-NP	O
surgery	surgery	NN	I-NP	O
agrees	agree	NNS	I-NP	O
and	and	CC	I-NP	O
patient	patient	NN	I-NP	O
should	should	MD	B-VP	O
follow	follow	VB	I-VP	O
with	with	IN	B-PP	O
podiatry	podiatry	NN	B-NP	O
for	for	IN	B-PP	O
toe	toe	NN	B-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Endo	Endo	AFX	O	B-protein
-	-	HYPH	O	O
Pt	Pt	NN	B-NP	O
has	have	VBZ	B-VP	O
DM	DM	NN	B-NP	O
.	.	.	O	O

RISS	RISS	NN	B-NP	B-protein
,	,	,	O	O
ADA	ADA	NN	B-NP	B-protein
.	.	.	O	O

Endo	Endo	NNP	B-NP	O
consult	consult	NN	I-NP	O
called	call	VBN	B-VP	O
and	and	CC	I-VP	O
recommended	recommend	VBN	I-VP	O
while	while	IN	B-SBAR	O
in	in	IN	B-PP	O
house	house	NN	B-NP	O
coverage	coverage	NN	I-NP	O
with	with	IN	B-PP	O
Novolog	Novolog	NN	B-NP	O
SS	SS	NN	I-NP	O
and	and	CC	O	O
glyburide	glyburide	NN	B-NP	O
10mg	10mg	NN	I-NP	O
qd	qd	NN	I-NP	O
as	as	IN	B-PP	O
outpatient	outpatient	NN	B-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
insulin	insulin	NN	I-NP	B-protein
as	as	IN	B-PP	O
outpt	outpt	NN	B-NP	O
.	.	.	O	O

HbA1c	HbA1c	NN	B-NP	O
elevated	elevate	VBD	B-VP	O
at	at	IN	B-PP	O
7.9	7.9	CD	B-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
needs	need	VBZ	B-VP	O
better	good	JJR	B-NP	O
control	control	NN	I-NP	O
and	and	CC	O	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
seen	see	VBN	I-VP	O
by	by	IN	B-PP	O
endo	endo	NN	B-NP	O
as	as	IN	B-PP	O
outpatient	outpatient	NN	B-NP	O
.	.	.	O	O

Also	Also	RB	B-ADVP	O
will	will	MD	B-VP	O
do	do	VB	I-VP	O
24h	24h	JJ	B-NP	O
urine	urine	NN	I-NP	O
cortisol	cortisol	NN	I-NP	O
as	as	IN	B-PP	O
outpatient	outpatient	NN	B-NP	O
to	to	TO	B-PP	O
eval	eval	NN	B-NP	O
cushing	cushing	NN	I-NP	O
's	's	POS	B-NP	O
as	as	IN	B-PP	O
outpt	outpt	NN	B-NP	O
as	as	IN	B-SBAR	O
recommended	recommend	VBN	B-VP	O
by	by	IN	B-PP	O
endo	endo	NN	B-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Heme	Heme	NNP	B-NP	B-protein
-	-	HYPH	O	O
Mech	Mech	NNP	B-NP	O
Valve	Valve	NNP	I-NP	O
-	-	HYPH	O	O
>	>	SYM	O	O
goal	goal	NN	B-NP	O
INR	INR	NN	I-NP	O
2.5	2.5	CD	B-NP	O
to	to	TO	B-PP	O
3.5	3.5	CD	B-NP	O
,	,	,	O	O
on	on	IN	B-PP	O
coumadin	coumadin	NN	B-NP	O
qdaily	qdaily	RB	B-ADVP	O
.	.	.	O	O

INR	INR	NN	B-NP	O
therapeutic	therapeutic	JJ	B-ADJP	O
throughout	throughout	IN	B-PP	O
hospitalization	hospitalization	NN	B-NP	O
.	.	.	O	O

Will	Will	MD	B-VP	O
be	be	VB	I-VP	O
followed	follow	VBN	I-VP	O
by	by	IN	B-PP	O
UGH	UGH	NN	B-NP	O
coumadin	coumadin	NN	I-NP	O
clinic	clinic	NN	I-NP	O
closely	closely	RB	B-ADVP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

FEN	FEN	NN	B-NP	O
-	-	HYPH	I-NP	O
Mg/K	Mg/K	NN	I-NP	B-protein
SS	SS	NN	I-NP	I-protein
;	;	:	O	O
BID	BID	NN	B-NP	O
lytes	lyte	NNS	I-NP	O
when	when	WRB	B-ADVP	O
diuresed	diurese	VBN	B-VP	O
with	with	IN	B-PP	O
IV	IV	CD	B-NP	O
lasix	lasix	NN	I-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

Psych	Psych	NN	B-NP	O
-	-	HYPH	B-PP	O
continued	continue	VBN	B-NP	O
psych	psych	NN	I-NP	O
meds	med	NNS	I-NP	O
as	as	IN	B-PP	O
inpatient	inpatient	NN	B-NP	O
with	with	IN	B-PP	O
good	good	JJ	B-NP	O
result	result	NN	I-NP	O
.	.	.	O	O

8	8	CD	B-NP	O
.	.	.	O	O

PPX	PPX	NN	B-NP	B-protein
-	-	:	O	O
on	on	IN	B-PP	O
coumadin	coumadin	NN	B-NP	O
,	,	,	O	O
gi	gi	NN	B-NP	O
with	with	IN	B-PP	O
h2	h2	NN	B-NP	O
blocker	blocker	NN	I-NP	O
ADDITIONAL	ADDITIONAL	NN	I-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Please	Please	NNP	I-NP	O
take	take	VB	B-VP	O
all	all	DT	B-NP	O
your	your	PRP$	I-NP	O
home	home	NN	I-NP	O
medications	medication	NNS	I-NP	O
plus	plus	CC	O	O
a	a	DT	B-NP	O
new	new	JJ	I-NP	O
medication	medication	NN	I-NP	O
-	-	HYPH	I-NP	O
azithromycin	azithromycin	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
continued	continue	VBN	I-VP	O
until	until	IN	B-PP	O
4/23	4/23	CD	B-NP	O
-RRB-	-RRB-	HYPH	B-NP	O
2	2	CD	I-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
Please	Please	NNP	I-NP	O
follow	follow	VB	B-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Goldey	Goldey	NNP	I-NP	O
,	,	,	O	O
coumadin	coumadin	NN	B-NP	O
clinic	clinic	NN	I-NP	O
,	,	,	O	O
opthalmology	opthalmology	NN	B-NP	O
,	,	,	O	O
endocrinology	endocrinology	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
podiatry	podiatry	NN	B-NP	B-protein
.3	.3	NN	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
Please	Please	NNP	I-NP	I-protein
call	call	VB	B-VP	O
your	your	PRP$	B-NP	O
doctor	doctor	NN	I-NP	O
or	or	CC	O	O
present	present	JJ	B-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
emergency	emergency	NN	I-NP	O
department	department	NN	I-NP	O
if	if	IN	B-SBAR	O
you	you	PRP	B-NP	O
experience	experience	VBP	B-VP	O
high	high	JJ	B-NP	O
fever	fever	NN	I-NP	O
,	,	,	O	O
trouble	trouble	NN	B-NP	O
breathing	breathing	NN	I-NP	O
,	,	,	O	O
weight	weight	NN	B-NP	O
gain	gain	NN	I-NP	O
>	>	SYM	O	O
5	5	CD	B-NP	O
lb	lb	NN	I-NP	O
in	in	IN	B-PP	O
3days	3day	NNS	B-NP	O
,	,	,	O	O
confusion	confusion	NN	B-NP	O
or	or	CC	O	O
any	any	DT	B-NP	O
other	other	JJ	I-NP	O
symptom	symptom	NN	I-NP	O
concerning	concern	VBG	B-VP	O
to	to	TO	B-PP	O
you	you	PRP	B-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
PCP	PCP	NN	B-NP	O
:	:	:	O	O
*	*	SYM	B-NP	O
f/u	f/u	NN	I-NP	O
Na	Na	NN	I-NP	O
and	and	CC	O	O
consider	consider	VB	B-VP	O
cortisol	cortisol	NN	B-NP	O
testing	testing	NN	I-NP	O
*	*	SYM	B-NP	O
appearance	appearance	NN	I-NP	O
of	of	IN	B-PP	O
cellulitis	cellulitis	NN	B-NP	O
R	R	NN	I-NP	O
foot	foot	NN	I-NP	O
VNA	VNA	NN	I-NP	O
:	:	:	O	O
*	*	SYM	B-NP	O
please	please	NN	I-NP	O
apply	apply	NN	I-NP	O
xeroform	xeroform	NN	I-NP	O
dressing	dressing	NN	I-NP	O
+	+	SYM	B-NP	O
dry	dry	NN	I-NP	O
dressing	dress	VBG	B-VP	O
to	to	TO	I-VP	O
2nd	2nd	VB	I-VP	O
toe	toe	NN	B-NP	O
interspace	interspace	NN	I-NP	O
of	of	IN	B-PP	O
right	right	JJ	B-NP	O
foot	foot	NN	I-NP	O
*	*	SYM	B-NP	O
please	please	NN	I-NP	O
check	check	NN	I-NP	O
breathing	breathing	NN	I-NP	O
,	,	,	O	O
o2	o2	NN	B-NP	O
sat	sit	VBD	B-VP	O
,	,	,	O	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
weight	weight	NN	B-NP	O
and	and	CC	O	O
call	call	VB	B-VP	O
Dr.	Dr.	NNP	B-NP	O
Earl	Earl	NNP	I-NP	O
Frankiewicz	Frankiewicz	NNP	I-NP	O
if	if	IN	B-SBAR	O
pt	pt	NN	B-NP	O
.	.	.	O	O

desats	desat	NNS	B-NP	O
or	or	CC	I-NP	O
gains	gain	NNS	I-NP	O
>	>	SYM	B-NP	O
5	5	CD	B-NP	O
lb	lb	NN	I-NP	O
in	in	IN	B-PP	O
3	3	CD	B-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
IACOVISSI	IACOVISSI	NNP	B-NP	O
,	,	,	O	O
TEDDY	TEDDY	NNP	B-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
LK23	LK23	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
4/4/05	4/4/05	CD	I-NP	O
@	@	NN	I-NP	O
01	01	CD	I-NP	O
:	:	:	O	O
27	27	CD	B-NP	O
PM	PM	NN	I-NP	O
******	******	SYM	B-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

